ERBA Diagnostics to showcase full range of products at AACC annual meeting

ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, is pleased to announce that Suresh Vazirani, Chairman of ERBA Diagnostics, will be a key note speaker at the International Marketing Brief (IMB) in conjunction with the AACC. Over 800 of the owners and senior officers of worldwide diagnostic companies and distributors are expected to attend the event.

ERBA Diagnostics Inc., USA will be exhibiting the full range of products from ERBA international group of companies in USA, Italy, Czech Republic, India and Turkey, including not only the Autoimmune and Infectious Elisa product lines, but also the full line of biochemistry, clinical chemistry and urine analysis products. About 10,000 potential customers are expected to visit the Expo from all regions of the world.

ERBA will also be exhibiting for the first time in USA its new prototype of its state-of-the-art microtiter and IFA processor LISA XL.

Most recently, IVAX Diagnostics, Inc. (NYSE MKT: IVD) has become ERBA Diagnostics (NYSE MKT: ERB). With this corporate name and ticker symbol change, ERBA Diagnostics signals its serious intention to develop brand recognition and collaboration through the worldwide network of companies affiliated with its majority stockholder - ERBA Diagnostics Mannheim GmbH.